Stay updated on LN-144 Clinical Trial in Metastatic Melanoma
Sign up to get notified when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.

Latest updates to the LN-144 Clinical Trial in Metastatic Melanoma page
- Check6 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1; no user-visible changes to the study details, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedThe Publications section text was updated to indicate automatic population from PubMed, and a new revision note (v3.3.1) was added, replacing the prior PubMed-related wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check20 days agoChange DetectedThe government funding lapse notice was removed from the page. The study details content remains unchanged.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe screenshots show only minor formatting updates and a new last updated timestamp; no core content changes to the study details, eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedLocation region and address updates to Auvergne-Rhône-Alpes with a new version tag v3.2.0; added government operating-status notice.SummaryDifference4%

- Check70 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to LN-144 Clinical Trial in Metastatic Melanoma
Enter your email address, and we'll notify you when there's something new on the LN-144 Clinical Trial in Metastatic Melanoma page.